Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression analysis in response to hypoxic pathway inhibition

ABSTRACT: Gene expression analysis in response to hypoxic pathway inhibition

PROVIDER: PRJNA494075 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7945360_1.fastq.gz	Fastqsanger.gz
	SRR7945360_2.fastq.gz	Fastqsanger.gz
	SRR7945361_1.fastq.gz	Fastqsanger.gz
	SRR7945361_2.fastq.gz	Fastqsanger.gz
	SRR7945362_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Gene expression analysis in response to hypoxic pathway inhibition

Project description:Gene expression analysis of HeLa cells exposed to hypoxia (1% Oxygen), treated with a PHD inhibitor (IOX2) or treated with a VHL inhibitor (VH032) for 16 hours

2019-01-15 | GSE120675 | GEO

Gene Expression Analysis of the response to ACC inhibition

Project description:Gene Expression Analysis of the response to ACC inhibition

| PRJNA625957 | ENA

Inhibition of integrated stress response promotes primordial follicle activation via the mTOR pathway

Project description:Inhibition of integrated stress response promotes primordial follicle activation via the mTOR pathway

| PRJNA1198894 | ENA

Evolutionary rewiring of the ROX genes controlling hypoxic response in yeasts

Project description:Unusually among fungi, Saccharomyces cerevisiae is able to grow in environments containing almost no oxygen. A major feature of its response to hypoxia is a transition in expression from aerobic to hypoxic genes, which often code for duplicated isoforms of the same protein. In aerobic conditions, expression of the hypoxic gene set is repressed by the HMG domain protein Rox1. Here, we examined the evolution of ROX1 and related genes in the subphylum Saccharomycotina and find that a substantial reorganization of hypoxic gene regulation occurred during yeast evolution. S. cerevisiae lost ROX2, an ancient paralog of ROX1, which is almost universally present in other yeast species. ROX2 is orthologous to Candida albicans RFG1, a regulator of filamentous growth. Many yeasts, such as Candida glabrata, lack ROX1 and contain only ROX2. Others such as Naumovozyma castellii retain both genes. Although the ancestral function of ROX2 is uncertain, we find that it is not a regulator of hypoxic genes except in C. glabrata where it has taken over this function from the absent ROX1. We also find that N. castellii has a greatly attenuated transcriptional response to hypoxia as compared to other species, but that the ergosterol pathway which is normally induced by hypoxia can be induced by cobalt chloride stress in N. castellii.

2018-07-31 | GSE75235 | GEO

Effect of ARNT on hypoxic response in Panc1 cells

Project description:The hypoxic response is influence by both the tissue of origin and local environmental influences. The hypoxic response is mediated in large part by the hypoxia-inducible transcription factors HIF-1 and HIF-2, which share a common beta subunit (also called ARNT). We looked at Panc1 cells, a pancreatic adenocarcinoma cell line, and compared the response to hypoxia in both regular tissue culture media and in pancreatic TIFM (tumor interstitial fluid media), and assessed the degree to which ARNT knockout mediates the observed changes

2026-04-15 | GSE320200 | GEO

Temporal proteomic analysis unravels the hypoxic response of melanoma cells

Project description:Hypoxia is a common feature in various solid tumors including melanoma. Cancer cells in hypoxic environments are resistant to both chemotherapy and radiation. Hypoxia is also associated with immune suppression. Identification of proteins and pathways that regulate survival of cancer cells in hypoxic environments can reveal potential vulnerabilities that can be exploited to improve efficacy of anti-cancer therapy. We carried out global proteome and phosphoproteome profiling in melanoma cell lines to identify proteins and pathways that are induced by hypoxia. Here, using Orbitrap Fusion Mass Spectrometer for analysis and employing TMT-based quantitation, we report >7,000 proteins and >10,000 phosphosites. As expected, several proteins that are known targets of hypoxia inducible factors (HIFs) were found to be overexpressed in the hypoxic models. In addition, several metabolic enzymes showed altered expression revealing metabolic reprogramming in hypoxic conditions. Phosphoproteomic profiling revealed kinase mediated signaling pathways that are induced in hypoxic conditions. Our data provides a comprehensive view of proteomic and phosphoproteomic alterations in hypoxia and reveals potential mechanisms that regulate cell survival in hypoxic environments. These mechanisms can be targeted to improve therapeutic outcomes in cancer treatment. Further, we identify the 20S proteasome as a putative therapeutic target in melanoma.

2021-05-31 | PXD019832 | Pride

Transcriptional elongation control of hypoxic response and therapeutic approaches

Project description:The release of paused RNA polymerase II (RNAPII) from promoter-proximal regions is tightly controlled to ensure proper regulation of gene expression. The elongation factor PTEF-b is known to release paused RNAPII via phosphorylation of the RNAPII C-terminal domain by its cyclin-dependent kinase component, CDK9. However, the signal and stress-specific roles of the various RNAPII-associated macromolecular complexes containing PTEF-b/CDK9 are not yet clear. Here, we identify and characterize the CDK9 complex required for transcriptional response to hypoxia. Contrary to previous reports, our data indicate that a CDK9 complex containing BRD4 but not AFF1/4 is essential for this hypoxic stress response. We demonstrate that BRD4 bromodomains (BET) are dispensable for the release of paused RNAPII at hypoxia-activated genes and that BET inhibition by JQ1 is insufficient to impair hypoxic gene response. Mechanistically, we demonstrate that the C-terminal region of BRD4 is required for Polymerase-Associated Factor-1 Complex (PAF1C) recruitment to establish an elongation-competent RNAPII complex at hypoxia-responsive genes. PAF1C disruption using a small-molecule inhibitor (iPAF1C) impairs hypoxia-induced, BRD4-mediated RNAPII release. Together, our results provide insight into potentially targetable mechanisms that control the hypoxia-responsive transcriptional elongation.

2024-06-27 | GSE244754 | GEO

PHD inhibition upregulates glycolytic pathway in OGD

Project description:PHD inhibition upregulates glycolytic pathway in OGD

| PRJNA534084 | ENA

Effect of ARNT on hypoxic response in Panc1 cells

Project description:Effect of ARNT on hypoxic response in Panc1 cells

| PRJNA1427132 | ENA

Histone methylation landscape in response to short hypoxic exposure

Project description:Histone methylation landscape in response to short hypoxic exposure

| PRJNA492793 | ENA